BriaCell Therapeutics Corp (NASDAQ:BCTX) has a beta value of 1.37 and has seen 2.1 million shares traded in the recent trading session. The company, currently valued at $24.97M, closed the recent trade at $0.69 per share which meant it gained $0.01 on the day or 1.35% during that session. The BCTX stock price is -765.22% off its 52-week high price of $5.97 and 33.33% above the 52-week low of $0.46. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.9 million shares traded. The 3-month trading volume is 4.98 million shares.
BriaCell Therapeutics Corp (NASDAQ:BCTX) trade information
Sporting 1.35% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BCTX stock price touched $0.69 or saw a rise of 15.98%. Year-to-date, BriaCell Therapeutics Corp shares have moved -88.20%, while the 5-day performance has seen it change 20.75%. Over the past 30 days, the shares of BriaCell Therapeutics Corp (NASDAQ:BCTX) have changed -22.01%. Short interest in the company has seen 0.75 million shares shorted with days to cover at 0.2.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BriaCell Therapeutics Corp (BCTX) estimates and forecasts
Figures show that BriaCell Therapeutics Corp shares have underperformed across the wider relevant industry. The company’s shares have lost -55.18% over the past 6 months, with this year growth rate of -100.00%, compared to 17.90% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 47.85% over the past 5 years.
BCTX Dividends
BriaCell Therapeutics Corp is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
